Dr Linda Rieswijk, Ph.D. (L.)

Uitgebreid profiel is alleen beschikbaar in Engels.

Phillips, R. V., Rieswijk, L., Hubbard, A. E., Vermeulen, R., Zhang, J., Hu, W., Li, L., Bassig, B. A., Wong, J. Y. Y., Reiss, B., Huang, Y., Wen, C., Purdue, M., Tang, X., Zhang, L., Smith, M. T., Rothman, N., & Lan, Q. (2019). Human exposure to trichloroethylene is associated with increased variability of blood DNA methylation that is enriched in genes and pathways related to autoimmune disease and cancer. Epigenetics, 14(11), 1112-1124. https://doi.org/10.1080/15592294.2019.1633866

Meer informative over deze publicatie

Luderer, U., Eskenazi, B., Hauser, R., Korach, K. S., McHale, C. M., Moran, F., Rieswijk, L., Solomon, G., Udagawa, O., Zhang, L., Zlatnik, M., Zeise, L., & Smith, M. T. (2019). Proposed Key Characteristics of Female Reproductive Toxicants as an Approach for Organizing and Evaluating Mechanistic Data in Hazard Assessment. Environmental Health Perspectives, 127(7), Article 075001. https://doi.org/10.1289/EHP4971

Meer informative over deze publicatie

AstraZeneca-Sanger Drug Combination DREAM Consortium (2019). Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen. Nature Communications, 10, Article 2674. https://doi.org/10.1038/s41467-019-09799-2

Meer informative over deze publicatie

Guyton, K. Z., Rieswijk, L., Wang, A., Chiu, W. A., & Smith, M. T. (2018). Key Characteristics Approach to Carcinogenic Hazard Identification. Chemical Research in Toxicology, 31(12), 1290-1292. https://doi.org/10.1021/acs.chemrestox.8b00321

Meer informative over deze publicatie

Nymark, P., Rieswijk, L., Ehrhart, F., Jeliazkova, N., Tsiliki, G., Sarimveis, H., Evelo, C. T., Hongisto, V., Kohonen, P., Willighagen, E., & Grafstrom, R. C. (2018). A Data Fusion Pipeline for Generating and Enriching Adverse Outcome Pathway Descriptions. Toxicological Sciences, 162(1), 264-275. https://doi.org/10.1093/toxsci/kfx252

Meer informative over deze publicatie

Moodley, K., Rieswijk, L., Oprea, T. I., & Dumontier, M. (2017). Assessing the quality of manually curated drug indication and usage information via ontology term mappings. Paper presented at Bio-Ontologies, Prague, Czech Republic.

Meer informative over deze publicatie

Rieswijk, L., Brauers, K. J. J., Coonen, M. L. J., Jennen, D. G. J., van Breda, S. G. J., & Kleinjans, J. C. S. (2016). Exploiting microRNA and mRNA profiles generated in vitro from carcinogen-exposed primary mouse hepatocytes for predicting in vivo genotoxicity and carcinogenicity. Mutagenesis, 31(5), 603-615. https://doi.org/10.1093/mutage/gew027

Meer informative over deze publicatie

Rieswijk, L., Claessen, S. M. H., Bekers, O., van Herwijnen, M., Theunissen, D. H. J., Jennen, D. G. J., de Kok, T., Kleinjans, J. C. S., & van Breda, S. G. J. (2016). Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma. Toxicology, 350, 31-39. https://doi.org/10.1016/j.tox.2016.05.002

Meer informative over deze publicatie

Rieswijk, L. (2016). MicroRNAs and epigenetics in chemical carcinogenesis : an integrative toxicogenomics-based approach. [Doctoral Thesis, Maastricht University]. Uitgeverij BOXPress. https://doi.org/10.26481/dis.20160120lr

Meer informative over deze publicatie

Rieswijk, L., Brauers, K. J. J., Coonen, M. L. J., Van Breda, S. G. J., Jennen, D. G. J., & Kleinjans, J. C. S. (2015). Evaluating microRNA profiles reveals discriminative responses following genotoxic or non-genotoxic carcinogen exposure in primary mouse hepatocytes. Mutagenesis, 30(6), 771-784. https://doi.org/10.1093/mutage/gev036

Meer informative over deze publicatie